Sheldon L. Koenig
2020 - Esperion Therapeutics
In 2020, Sheldon L. Koenig earned a total compensation of $23.2K as President and Chief Executive Officer at Esperion Therapeutics.
Compensation breakdown
| Salary | $23,182 |
|---|---|
| Total | $23,182 |
Koenig received $23.2K in salary, accounting for 100% of the total pay in 2020.
Rankings
In 2020, Sheldon L. Koenig's compensation ranked 13,020th out of 13,090 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,020 out of 13,090 | 1st |
Division Manufacturing | 5,595 out of 5,621 | 1st |
Major group Chemicals And Allied Products | 2,245 out of 2,254 | 0th |
Industry group Drugs | 1,947 out of 1,954 | 0th |
Industry Pharmaceutical Preparations | 1,455 out of 1,459 | 0th |
Source: SEC filing on April 14, 2022.
Koenig's colleagues
We found three more compensation records of executives who worked with Sheldon L. Koenig at Esperion Therapeutics in 2020.
News
Esperion Therapeutics CEO Sheldon Koenig's 2023 pay falls 22% to $3M
April 11, 2024
Esperion Therapeutics CEO Sheldon Koenig's 2022 pay falls 51% to $3.8M
April 13, 2023
Esperion Therapeutics CEO Tim Mayleben's 2021 pay rises 19% to $8.2M
April 14, 2022
Portola Pharmaceuticals CEO Scott Garland's 2019 pay falls 24% to $4.4M
April 20, 2020